Empagliflozin
MMELIFT01
Unknown small_molecule completed
Quick answer
Empagliflozin for Non Alcoholic Fatty Liver Disease is a Unknown program (small_molecule) at MEDA Pharma GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MEDA Pharma GmbH & Co. KG
- Indication
- Non Alcoholic Fatty Liver Disease
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed